# BMS-247550 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy

> **NCT00004927** · PHASE1 · COMPLETED · sponsor: **R-Pharm**

## Conditions studied

- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** ixabepilone

## Key facts

- **NCT ID:** NCT00004927
- **Lead sponsor:** R-Pharm
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-07
- **Primary completion:** 2002-10
- **Final completion:** 2002-10
- **Target enrollment:** — (—)
- **Last updated:** 2017-01-30

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004927

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004927, "BMS-247550 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00004927. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*